NOVT Novanta Inc.
NOVT Novanta Inc.
Technology · Scientific & Technical Instruments
Desk view
Market read
POC $142.21 · VWAP $135.15 · +4.2% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
2 watchlists
NOVT Price Structure
Loading timeframes…
Peers
Every watchlist NOVT belongs to, members best 30-day change first — NOVT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@robotics
@ai-bottlenecks
Reported the quarter ending 2026-07-03: revenue $266M, diluted EPS $0.30, net income $13M (SEC filing). Across the print the stock moved +2.4% (close before → first close after).
full note →Against street estimates
How NOVT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about NOVT from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 23
- Novanta Inc. (NOVT) Q2 FY2026 earnings call transcript
- NOVT Stock Price | Novanta Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
- Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call
- Novanta Announces Financial Results for the Second Quarter 2026
- Novanta Inc. - Novanta Completes Acquisition of Riverpoint Medical
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
NOVT research tape
19 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.